75 related articles for article (PubMed ID: 17429684)
1. Intermediate conductance Ca
Numata T; Sato-Numata K; Yoshino M
Front Insect Sci; 2022; 2():1100671. PubMed ID: 38468799
[TBL] [Abstract][Full Text] [Related]
2. Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia.
Zhang Y; Sun J; Gao J; Sun W; Xu L; Zhai C; Su W; Wang H
Front Pharmacol; 2024; 15():1347880. PubMed ID: 38344176
[TBL] [Abstract][Full Text] [Related]
3. Hypokalemia after rituximab administration in nephrotic syndrome: two case reports.
Song Y; Ding L; An X; Zhao Y; Li X; Yang X; Xiao X
BMC Nephrol; 2023 Jul; 24(1):214. PubMed ID: 37464309
[TBL] [Abstract][Full Text] [Related]
4. Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.
Capatina AL; Lagos D; Brackenbury WJ
Rev Physiol Biochem Pharmacol; 2022; 183():1-43. PubMed ID: 32865696
[TBL] [Abstract][Full Text] [Related]
5. Let's Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia.
Deak D; Pop C; Zimta AA; Jurj A; Ghiaur A; Pasca S; Teodorescu P; Dascalescu A; Antohe I; Ionescu B; Constantinescu C; Onaciu A; Munteanu R; Berindan-Neagoe I; Petrushev B; Turcas C; Iluta S; Selicean C; Zdrenghea M; Tanase A; Danaila C; Colita A; Colita A; Dima D; Coriu D; Einsele H; Tomuleasa C
Front Immunol; 2019; 10():2856. PubMed ID: 31921126
[No Abstract] [Full Text] [Related]
6. Altered expression and functional role of ion channels in leukemia: bench to bedside.
Rafieemehr H; Samimi A; Maleki Behzad M; Ghanavat M; Shahrabi S
Clin Transl Oncol; 2020 Mar; 22(3):283-293. PubMed ID: 31280433
[TBL] [Abstract][Full Text] [Related]
7. KCa3.1 as an Effective Target for Inhibition of Growth and Progression of Intrahepatic Cholangiocarcinoma.
Song P; Du Y; Song W; Chen H; Xuan Z; Zhao L; Chen J; Chen J; Guo D; Jin C; Zhao Y; Tuo B; Zheng S
J Cancer; 2017; 8(9):1568-1578. PubMed ID: 28775776
[No Abstract] [Full Text] [Related]
8. SK4 channels modulate Ca
Steudel FA; Mohr CJ; Stegen B; Nguyen HY; Barnert A; Steinle M; Beer-Hammer S; Koch P; Lo WY; Schroth W; Hoppe R; Brauch H; Ruth P; Huber SM; Lukowski R
Mol Oncol; 2017 Sep; 11(9):1172-1188. PubMed ID: 28557306
[TBL] [Abstract][Full Text] [Related]
9. Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis.
Faouzi M; Hague F; Geerts D; Ay AS; Potier-Cartereau M; Ahidouch A; Ouadid-Ahidouch H
Oncotarget; 2016 Jun; 7(24):36419-36435. PubMed ID: 27183905
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the TREK-1 K2P potassium channels in prostate cancer.
Zhang GM; Wan FN; Qin XJ; Cao DL; Zhang HL; Zhu Y; Dai B; Shi GH; Ye DW
Oncotarget; 2015 Jul; 6(21):18460-8. PubMed ID: 25962960
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression.
Song X; Liu BC; Lu XY; Yang LL; Zhai YJ; Eaton AF; Thai TL; Eaton DC; Ma HP; Shen BZ
Biochim Biophys Acta; 2014 May; 1843(5):894-901. PubMed ID: 24518247
[TBL] [Abstract][Full Text] [Related]
12. K(+) channels and cell cycle progression in tumor cells.
Ouadid-Ahidouch H; Ahidouch A
Front Physiol; 2013; 4():220. PubMed ID: 23970866
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model.
Chernet BT; Levin M
Dis Model Mech; 2013 May; 6(3):595-607. PubMed ID: 23471912
[TBL] [Abstract][Full Text] [Related]
14. Multiple cholinergic signaling pathways in pituitary gonadotrophs.
Zemkova H; Kucka M; Bjelobaba I; Tomic M; Stojilkovic SS
Endocrinology; 2013 Jan; 154(1):421-33. PubMed ID: 23161872
[TBL] [Abstract][Full Text] [Related]
15. Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors.
Wang LH; Wang N; Lu XY; Liu BC; Yanda MK; Song JZ; Dai HM; Sun YL; Bao HF; Eaton DC; Ma HP
Biochim Biophys Acta; 2012 Feb; 1823(2):505-13. PubMed ID: 22192444
[TBL] [Abstract][Full Text] [Related]
16. Calcium-activated K+ channels increase cell proliferation independent of K+ conductance.
Millership JE; Devor DC; Hamilton KL; Balut CM; Bruce JI; Fearon IM
Am J Physiol Cell Physiol; 2011 Apr; 300(4):C792-802. PubMed ID: 21123738
[TBL] [Abstract][Full Text] [Related]
17. The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors.
Roy JW; Cowley EA; Blay J; Linsdell P
Br J Pharmacol; 2010 Feb; 159(3):650-8. PubMed ID: 20050851
[TBL] [Abstract][Full Text] [Related]
18. A PI3-kinase-mediated negative feedback regulates neuronal excitability.
Howlett E; Lin CC; Lavery W; Stern M
PLoS Genet; 2008 Nov; 4(11):e1000277. PubMed ID: 19043547
[TBL] [Abstract][Full Text] [Related]
19. An intermediate-conductance Ca(2+)-activated K (+) channel mediates B lymphoma cell cycle progression induced by serum.
Wang J; Xu YQ; Liang YY; Gongora R; Warnock DG; Ma HP
Pflugers Arch; 2007 Sep; 454(6):945-56. PubMed ID: 17429684
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
